| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,659 | 9,110 | 9,513 | 10,009 | | Cost of Revenue | 849 | 1,152 | 1,210 | 1,125 | | | Gross Profit | 8,810 | 7,958 | 8,303 | 8,884 | | | Operating Expenses | | Research Development | 4,061 | 3,996 | 4,075 | 5,039 | | Selling General and Administrative | 3,153 | 3,208 | 3,108 | 3,333 | | Non Recurring |
-
|
-
|
-
| 584 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,596 | 754 | 1,120 | (72) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (950) | 2,375 | 476 | 1,514 | | Earnings Before Interest And Taxes | 2,147 | 3,129 | 1,596 | 1,442 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 2,147 | 3,129 | 1,596 | 1,442 | | Income Tax Expense | 394 | 814 | 228 | 482 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,753 | 2,315 | 1,368 | 960 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,753 | 2,315 | 1,368 | 960 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,753 | $2,315 | $1,368 | $960 |
|
0.51% Nasdaq 
0.13 (1.04%) 
Income Statement
